Vasomotor symptoms and coronary artery calcium in postmenopausal women

Menopause

Volumn 17, Issue 6, 2010, Pages 1136-1145

  Allison, Matthew A ^a   Manson, JoAnn E ^b   Aragaki, Aaron ^c   Langer, Robert D ^d   Rossouw, Jacques ^e   Curb, David ^f   Martin, Lisa W ^g   Phillips, Lawrence ^h   Stefanick, Marcia L ⁱ   Cochrane, Barbara B ^j   Sarto, Gloria ^k   Barnhart, Janice ^l   O'Sullivan, Mary Jo ^m   Johnson, Karen C ⁿ   Gass, Margery ^o   Trevisan, Maurizio ^p   Woods, Nancy F ^j  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d Jackson Hole Center for Preventive Medicine   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f UNIVERSITY OF HAWAII   (United States)

^g GEORGE WASHINGTON UNIVERSITY   (United States)

^h EMORY UNIVERSITY   (United States)

ⁱ STANFORD UNIVERSITY   (United States)

^j UNIVERSITY OF WASHINGTON   (United States)

^k UNIVERSITY OF WISCONSIN MADISON   (United States)

^l Albert Einstein University   (United States)

^m UNIVERSITY OF MIAMI   (United States)

ⁿ UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^o UNIVERSITY OF CINCINNATI   (United States)

^p Nevada System of Higher Education   (United States)

more..

Author keywords

Atherosclerosis; Calcium; Coronary; Menopause; Vasomotor symptoms; Women

Indexed keywords

CALCIUM; CONJUGATED ESTROGEN; CORONARY ARTERY CALCIUM; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION ANALYSIS; FEMALE; HORMONAL THERAPY; HOT FLUSH; HUMAN; HYSTERECTOMY; NIGHT SWEAT; POSTMENOPAUSE; QUESTIONNAIRE; RISK REDUCTION; SCORING SYSTEM;

CALCIUM; CORONARY VESSELS; CROSS-SECTIONAL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEART; HOT FLASHES; HUMANS; HYSTERECTOMY; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; POSTMENOPAUSE; QUESTIONNAIRES; SWEATING; TOMOGRAPHY, X-RAY COMPUTED; VASOMOTOR SYSTEM;

EID: 78649658550     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181e664dc     Document Type: Article

References (44)

1. Porter M, Penney GC, Russell D, Russell E, Templeton A. A population based survey of women's experience of the menopause. BJOG 1996; 103:1025-1028.
2. NIH State-of-the-Science Panel. National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms. Ann Intern Med 2005;142:1003-1013.
3. Barnabei VM, Grady D, Stovall DW, et al. Menopausal symptoms in older women and the effects of treatment with hormone therapy. Obstet Gynecol 2002;100:1209-1218.
4. Simon J, Klaiber E, Wiita B, Bowen A, Yang HM. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women. Menopause 1999;6:138-146.
5. Guthrie JR, Dennerstein L, Hopper JL, Burger HG. Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women. Obstet Gynecol 1996;88:437-442.
6. Matthews KA, Wing RR, Kuller LH, Meilahn EN, Plantinga P. Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women. Arch Intern Med 1994;154:2349-2355.
7. Demer LL, Tintut Y. Mineral exploration: search for the mechanism of vascular calcification and beyond: the 2003 Jeffrey M. Hoeg Award lecture. Arterioscler Thromb Vasc Biol 2003;23:1739-1743.
8. Stary HC. Natural history of calcium deposits in atherosclerosis progression and regression. Z Kardiol 2000;89:28-35.
9. Allison MA, Criqui MH, Wright CM. Patterns and risk factors for systemic calcified atherosclerosis. Arterioscler Thromb Vasc Biol 2004;24:331-336.
10. Budoff M. Comparison of spiral and electron beam tomography in the evaluation of coronary calcification in asymptomatic persons. Int J Cardiol 2002;82:297-298.
11. Sangiorgi G, Rumberger JA, Severson A, et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 1998;31:126-133.
12. Haberl R, Becker A, Leber A, et al. Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1,764 patients. J Am Coll Cardiol 2001; 37:451-457.
13. Budoff MJ, Shaw LJ, Liu ST, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol 2007;49:1860-1870.
14. Kondos GT, Hoff JA, Sevrukov A, et al. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low-to intermediate-risk adults. Circulation 2003;107:2571-2576.
15. Greenland P, Bonow RO, Brundage BH, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2007;49:378-402.
16. Anderson GL, Manson J, Wallace R, et al. Implementation of the Women's Health Initiative study design. Ann Epidemiol 2003;13:S5-S17.
17. Carr JJ, Nelson JC, Wong ND, et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology 2005;234:35-43.
18. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-832.
19. Manson JE, Allison MA, Rossouw JE, et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007;356:2591-2602.
20. Khoury Z, Schwartz R, Gottlieb S, Chenzbraun A, Stern S, Keren A. Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound. Am J Cardiol 1997; 80:1429-1433.
21. FazioS,Linton MF. The inflamed plaque: cytokine production and cellular cholesterol balance in the vessel wall. Am J Cardiol 2001;88:12E-15E.
22. Libby P. Vascular biology of atherosclerosis: overview and state of the art. Am J Cardiol 2003;91:3A-6A.
23. DeBakey ME, Lawrie GM, Glaeser DH. Patterns of atherosclerosis and their surgical significance. Ann Surg 1985;201:115-131.
24. Bostrom K. Insights into the mechanism of vascular calcification. Am J Cardiol 2001;88:20E-22E.
25. Dhore CR, Cleutjens JP, Lutgens E, et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2001;21:1998-2003.
26. Engelse MA, Neele JM, Bronckers AL, Pannekoek H, de Vries CJ. Vascular calcification: expression patterns of the osteoblast-specific gene core binding factor >-1 and the protective factor matrix gla protein in human atherogenesis. Cardiovasc Res 2001;52:281-289.
27. Mody N, Tintut Y, Radcliff K, Demer LL. Vascular calcification and its relation to bone calcification: possible underlying mechanisms. J Nucl Cardiol 2003;10:177-183.
28. Allison MA, Wright CM. Age and gender are the strongest clinical correlates of prevalent coronary calcification (R1). Int J Cardiol 2005;98:325-330.
29. Bild DE, Detrano R, Peterson D, et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2005;111:1313-1320.
30. Freedman RR. Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes. Fertil Steril 1998;70:332-337.
31. Crandall CJ, Zheng Y, Crawford SL, et al. Presence of vasomotor symptoms is associated with lower bone mineral density: a longitudinal analysis. Menopause 2009;16:239-246.
32. Gast GC, Grobbee DE, Pop VJ, et al. Vasomotor symptoms are associated with a lower bone mineral density. Menopause 2009;16:231-238.
33. Sun L, Peng Y, Sharrow AC, et al. FSH directly regulates bone mass. Cell 2006;125:247-260.
34. Sowers MR, Jannausch M, McConnell D, et al. Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinol Metab 2006;91:1261-1267.
35. von Muhlen DG, Soroko S, Kritz-Silverstein D, Barrett-Connor E. Vasomotor symptoms are not associated with reduced bone mass in postmenopausal women: the Rancho Bernardo Study. J Womens Health Gend Based Med 2000;9:505-511.
36. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, Matthews KA. Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study. Circulation 2008;118:1234-1240.
37. Napoli N, Faccio R, Shrestha V, Bucchieri S, Rini GB, Armamento-Villareal R. Estrogen metabolism modulates bone density in men. Calcif Tissue Int 2007;80:227-232.
38. Lindsay R. The role of estrogen in the prevention of osteoporosis. Endocrinol Metab Clin North Am 1998;27:399-409.
39. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291:1701-1712.
40. Writing Group for the Women's Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
41. Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-1477.
42. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 1995;15:1512-1531.
43. Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994;89:2462-2478. (Pubitemid 24142837)
44. Svartberg J, von Mühlen D, Kritz-Silverstein D, Barrett-Connor E. Vasomotor symptoms and mortality: the Rancho Bernardo Study. Menopause 2009;16:888-891.